Toyomasa Katagiri

Director/Board Member at Cancer Precision Medicine KK

58 year

Health Technology

Consumer Services

Profile

Toyomasa Katagiri is currently the Director at Immunas Pharma, Inc. since 2014, Professor & Deputy Director at The University of Tokushima since 2008, and Director at Cancer Precision Medicine KK since 2018.
Previously, he served as an Outside Director at OncoTherapy Science, Inc. from 2010 to 2023.

Toyomasa Katagiri active positions

Companies	Position	Start
The University of Tokushima	Corporate Officer/Principal	2008-04-30
Immunas Pharma, Inc. Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million.	Director/Board Member	2014-11-30
Cancer Precision Medicine KK	Director/Board Member	2018-04-30

All active positions of Toyomasa Katagiri

Former positions of Toyomasa Katagiri

Companies	Position	End
ONCOTHERAPY SCIENCE, INC.	Director/Board Member	2023-03-30

See the detail of Toyomasa Katagiri's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Toyomasa Katagiri's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
ONCOTHERAPY SCIENCE, INC.	Health Technology

Private companies	2
Immunas Pharma, Inc. Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million.	Health Technology
Cancer Precision Medicine KK

See company connections

Stock Market
Insiders
Toyomasa Katagiri